anelyssa

A/Prof Anelyssa D’Abreu

Associate Professor of Neurology, University of Virginia
Anelyssa D’Abreu, MD, is a neurologist who specialises in geriatric neurology and movement disorders, caring for elderly patients with neurodegenerative disorders such as Alzheimer’s disease, Lewy body dementia, Parkinson’s disease, and dementia. Her primary research interest is the study of healthcare delivery models to improve care for patients and families affected by these disorders.Originally from Brazil, D’Abreu moved to attend medical school in Sao Paulo at the University of Campinas (Unicamp). She came to the U.S. to complete her residency training at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. D’Abreau then pursued a fellowship in geriatric neurology at Memorial Hospital of Rhode Island at Brown University in Providence, Rhode Island.

More from this expert

Clinical Articles iconClinical Articles

A little-known and poorly understood sleep disorder that occurs during the rapid eye movement, or REM, stage of sleep has been garnering attention for its role in foreshadowing neurodegenerative brain diseases such as Parkinson’s disease and dementia with Lewy bodies. The disorder, known as REM sleep behavior disorder, or RBD in the medical field, affects around 1% of the general population worldwide and about 2% of adults over 65.

A little-known and poorly understood sleep disorder that occurs during the rapid eye movement, or REM, stage of sleep has been garnering attention for its role in foreshadowing neurodegenerative brain diseases such as Parkinson’s disease and dementia with Lewy bodies. The disorder, known as REM sleep behavior disorder, or RBD in the medical field, affects around 1% of the general population worldwide and about 2% of adults over 65.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.